Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN110204547A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110204547A reveals a safer two-step synthesis for 1,3-dimethyl uric acid, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.